Share Your Research, Maximize Your Social Impacts
Will Dostarlimab Become the New Rectal Cancer Drug of Choice?
Journal: International Journal of Science and Research (IJSR) (Vol.11, No. 6)Publication Date: 2022-06-05
Authors : Motupalli Sankeerth Kumar; Ponnaluri Lalitha; Seelam Victor John Wilson;
Page : 1369-1369
Keywords : Dostarlimab; Rectal cancer; new drug of choice;
Source : Download
Find it from : Google Scholar
Abstract
Information on a recent clinical trial in the United States on a drug that has been shown to be nearly 100% effective against rectal cancer in the sample population.
Other Latest Articles
- Design & Fabrication of Manless Defense Robot
- The Life-Saving Mission for COVID-19 Vaccination on Google Cloud (GC) Ecosystem
- Problems Faced by the Physiotherapists Wearing PPE Kit While Treating the Covid Patients
- IoT Enabled Edge Computing Healthcare and Security System for Isolated Patients
- Assessment of Breast Feeding and Complementary Feeding Practices and Importance of Right Nutrition in the First 1000 Days of a Child?s Life
Last modified: 2022-09-07 15:17:07